Atara Biotherapeutics, Inc. (ATRA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Atara Biotherapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 6.94x | -1.17x | -0.20x | -1.47x | -4.34x | -4.74x |
| P/B Ratio | -5.89x | -1.02x | -0.55x | 2.64x | 5.28x | 3.14x |
| P/S Ratio | 1.88x | 0.77x | 6.34x | 5.26x | 72.58x | 0.00x |
| Profitability | ||||||
| Gross Margin | 82.4% | 83.7% | -3.7% | 100.0% | -1286.4% | 0.0% |
| Operating Margin | 29.7% | -64.7% | -3219.5% | -441.2% | -1673.9% | 0.0% |
| Net Margin | 27.1% | -66.2% | -3220.9% | -359.1% | -1672.3% | 0.0% |
| EBITDA Margin | 32.0% | -58.7% | -3102.7% | -349.6% | -1627.9% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 0.82x | 0.48x | 0.72x | 3.74x | 3.64x | 6.31x |
| Quick Ratio | 0.82x | 0.40x | 0.65x | 3.72x | 3.64x | 6.31x |
| Leverage | ||||||
| Debt/Equity | -1.37x | -0.45x | -0.58x | 0.57x | 0.10x | 0.03x |
YoY = year-over-year change. Source: FMP..